Angiotensin-(1-7) induces peripheral antinociception through mas receptor activation in an opioid-independent pathway

Pharmacology

Volumn 89, Issue 3-4, 2012, Pages 137-144

  Costa, Aline C O ^a   Becker, Lenice K ^a   Moraes, Éder R ^a   Romero, Thiago R L ^a   Guzzo, Luciana ^a   Santos, Robson A S ^a   Duarte, Igor D G ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

A 779; Angiotensin; Immunofluorescence; Mas receptor; Peripheral antinociception; Prostaglandin

Indexed keywords

ANGIOTENSIN RECEPTOR; ANGIOTENSIN[1-7]; ANGIOTENSIN[1-7][7 DEXTRO ALANINE]; G PROTEIN COUPLED RECEPTOR; MAS RECEPTOR; MORPHINE; NALOXONE; OPIATE PEPTIDE; PROSTAGLANDIN E2; UNCLASSIFIED DRUG;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG DOSE COMPARISON; DRUG EFFECT; HYPERALGESIA; IMMUNOFLUORESCENCE TEST; MALE; NOCICEPTION; NONHUMAN; PRESSURE; PRIORITY JOURNAL; RAT; SPINAL GANGLION;

ANALGESICS; ANGIOTENSIN II; ANIMALS; DINOPROSTONE; GANGLIA, SPINAL; HYPERALGESIA; MALE; PEPTIDE FRAGMENTS; PROTO-ONCOGENE PROTEINS; RATS; RATS, WISTAR; RECEPTORS, G-PROTEIN-COUPLED;

EID: 84857987227     PISSN: 00317012     EISSN: 14230313     Source Type: Journal    
DOI: 10.1159/000336340     Document Type: Article

References (49)

1. Santos RA, Ferreira AJ, Simões e Silva AC: Recent advances in the angiotensin-converting enzyme 2-Angiotensin(1-7)-Mas axis. Exp Physiol 2008; 93: 519-527. (Pubitemid 351595060)
2. Crackower MA, Oudit GY, Kozieradzki I, Sarao R, Sun H, Sasaki T, Hirsch E, Suzuki A, Shioi T, Irie-Sasaki J, Sah R, Cheng HY, Rybin VO, Lembo G, Fratta L, Oliveira-dos-Santos AJ, Benovic JL, Kahn CR, Izumo S, Steinberg SF, Wymann MP, Backx PH, Penninger JM: Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature 2002; 417: 822-828. (Pubitemid 34670323)
3. Donoghue M, Hsieh F, Baronas E, Godbout K, Gosselin M, Stagliano N, Donovan M, Woolf B, Robison K, Jeyaseelan R, Breitbart RE, Acton S: A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ Res 2000; 87:E1-E9.
4. Silva DM, Vianna HR, Cortes SF, Campagnole-Santos MJ, Santos RAS, Lemos VS: Evidence for a new angiotensin-(1-7) receptor subtype in the aorta of Sprague-Dawley rats. Peptides 2007; 28: 702-707. (Pubitemid 46204993)
5. Tipnis SR, Hooper NM, Hyde R, Karran E, Christie G, Turner AJ: A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captoprilinsensitive carboxypeptidase. J Biol Chem 2000; 275: 33238-33243.
6. Medeiros MAS, França MSF, Boileau G, Juliano L, Carvalho KM: Specific fluorogenic substrates for neprilysin (neutral endopeptidase, EC 3.4.24.11) which are highly resistant to serine- and metalloproteases. Braz J Med Biol Res 1997; 30: 1157-1162. (Pubitemid 127518401)
7. Jackson TR, Blair LA, Marshall J, Goedert M, Hanley MR: The Mas oncogene encodes an angiotensin receptor. Nature 1988; 335: 437-440.
8. Santos RA, Simoes e Silva AC, Maric C, Silva DM, Machado RP, De Buhr I, Heringer-Walther S, Pinheiro SV, Lopes MT, Bader M, Mendes EP, Lemos VS, Campagnole-Santos MJ, Schultheiss HP, Speth R, Walther T: Angiotensin-( 1-7) is an endogenous ligand for the G protein-coupled receptor Mas. Proc Natl Acad Sci USA 2003; 100: 8258-8263. (Pubitemid 36842532)
9. Santos RA, Campagnole-Santos MJ, Andrade SP: Angiotensin-(1-7): An update. Regul Pept 2000; 91: 45-62.
10. Stanziola L, Greene LJ, Santos RA: Effect of chronic angiotensin converting enzyme inhibition on angiotensin I and bradykinin metabolism in rats. Am J Hypertens 1999; 12: 1021-1029. (Pubitemid 29528702)
11. Pavel J, Tang H, Brimijoin S, Moughamian A, Nishioku T, Benicky J, Saavedra JM: Expression and transport of Angiotensin II AT1 receptors in spinal cord, dorsal root ganglia and sciatic nerve of the rat. Brain Res 2008; 1246: 111-122.
12. Pelegrini-da-Silva A, Martins AR, Prado WA: A new role for the renin-Angiotensin system in the rat periaqueductal gray matter: Angiotensin receptor-mediated modulation of nociception. Neuroscience 2005; 132: 453-463. (Pubitemid 40417917)
13. Sakagawa T, Okuyama S, Kawashima N, Hozumi S, Nakagawasai O, Tadano T, Kisara K, Ichiki T, Inagami T: Pain threshold, learning and formation of brain edema in mice lacking the angiotensin II type 2 receptor. Life Sci 2000; 67: 2577-2585.
14. Zamir N, Simantov R, Segal M: Pain sensitivity and opioid activity in genetically and experimentally hypertensive rats. Brain Res 1980; 184: 299-310. (Pubitemid 10186487)
15. Irvine R, White JM: The effects of central and peripheral angiotensin on hypertension and nociception in rats. Pharmacol Biochem Behav 1996; 57: 37-41.
16. Irvine R, White JM, Head RJ: The renin angiotensin system and nociception in spontaneously hypertensive rats. Life Sci 1995; 56: 1073-1078.
17. Toma N, Sgambato V, Couture R: Effect of angiotensin II on a spinal nociceptive reflex in the rat: Receptor and mechanism of action. Life Sci 1997; 61: 503-513. (Pubitemid 27301383)
18. Haulica I, Neamtu C, Stratone A, Petrescu G, Branisteanuy D, Saltineanu S: Evidence for the involvement of cerebral renin-Angiotensin system (RAS) in stress analgesia. Pain 1986; 27: 237-245. (Pubitemid 17184950)
19. Marques-Lopes J, Pinho D, Albino-Teixeira A, Tavares I: The hyperalgesic effects induced by the injection of angiotensin II into the caudal ventrolateral medulla are mediated by the pontine A5 noradrenergic cell group. Brain Res 2010; 1325: 41-52.
20. Randall LD, Selitto JJ: A method for measurement of analgesic activity on inflamed tissues. Arch Int Pharmacol 1957; 113: 233-249.
21. Block CH, Santos RAS, Brosnihan KB, Ferrario CM: Immunocytochemical localization of angiotensin-(1-7) in the rat forebrain. Peptides 1988; 9: 1395-1401. (Pubitemid 19265232)
22. Becker LK, Etelvino GM, Walther T, Santos RAS, Campagnole-Santos MJ: Immunofluorescence localization of the receptor Mas in cardiovascular-related areas of the rat brain. Am J Physiol Heart Circ Physiol 2007; 293: 1416-1424.
23. Paton JF, Kasparov S: Sensory channel specific modulation in the nucleus of the solitary tract. J Auton Nerv Syst 2000; 80: 117-129. (Pubitemid 30227496)
24. Huang Y, Wang DH: Role of AT1 and AT2 receptor subtypes in salt-sensitive hypertension induced by sensory nerve degeneration. J Hypertens 2001; 19: 1841-1846. (Pubitemid 32924951)
25. Ahmad Z, Milligan CJ, Paton JF, Deuchars J: Angiotensin type 1 receptor immunoreactivity in the thoracic spinal cord. Brain Res 2003; 985: 21-31. (Pubitemid 37272049)
26. MacGregor DP, Murone C, Song K, Allen AM, Paxinos G, Mendelsohn AO: Angiotensin II receptor subtypes in the human central nervous system. Brain Res 1995; 675: 231-240.
27. Oldfield BJ, Allen AM, Hards DK, McKinley MJ, Schlawe I, Mendelsohn FAO: Distribution of angiotensin II receptor binding in the spinal cord of the sheep. Brain Res 1994; 650: 40-48. (Pubitemid 24207042)
28. White SR, Penner JD, Speth RC, Chan JYH: Angiotensin II receptors in the spinal cord of the rat. Brain Res 1988; 441: 195-201. (Pubitemid 18059968)
29. Besson JM, Chaouch A: Peripheral and spinal mechanisms of nociception. Physiol Rev 1987; 67: 67-186. (Pubitemid 17056803)
30. Gehlert DR, Speth RC, Wamsley JK: Quantitative autoradiography of angiotensin II receptors in brain and kidney: Focus on cardiovascular implications. Prog Clin Biol Res 1985; 192: 241-249.
31. Mendelsohn FA, Quirion R, Saavedra JM, Aguilera G, Catt KJ: Autoradiographic localization of angiotensin II receptors in rat brain. Proc Natl Acad Sci USA 1984; 81: 1575-1579 (Pubitemid 14174546)
32. Stein C: Peripheral mechanisms of opioid analgesia. Anesth Analg 1993; 76: 182-191. (Pubitemid 23094833)
33. Negri L, Potenza RL, Corsi R, Melchiorri P: Evidence for two subtypes of - Opioid receptors in rat brain. Eur J Pharmacol 1991; 196: 335-336.
34. Vaughn LK, Wire WS, Davis P, Shimohigashi Y, Toth G, Knapp RJ, Hruby VJ, Burks TF, Yamamura HI: Differentiation between rat brain and mouse vas deferens -opioid receptors. Eur J Pharmacol 1990; 177: 99-101. (Pubitemid 20077958)
35. Fontes MAP, Silva LCS, Campagnole-Santos MJ, Khosla MC, Guertzenstein PG, Santos RAS: Evidence that angiotensin-(1-7) plays a role in the central control of blood pressure at the ventrolateral medulla acting through specific receptors. Brain Res 1994; 665: 175-180. (Pubitemid 24351095)
36. Kashiba H, Senba E, Ueda Y, Tohyama M: Co-lozalized but target-unrelated expression of vasoactive intestinal polypeptide and galanin in rat dorsal root ganglion neurons after peripheral nerve crush injury. Brain Res 1992; 582: 47-57.
37. Noguchi K, Senba E, Morita Y, Sato M, Tohyama M: Prepro-VIP and preprotachykinin mRNAs in the rat dorsal root ganglion cells following peripheral axotomy. Brain Res Mol Brain Res 1989; 6: 327-330. (Pubitemid 19283317)
38. Xu XJ, Puke MJ, Verge VM, Wiesenfeld-Hallin Z, Hughes J, Hokfelt T: Up-regulation of cholecystokinin in primary sensory neurons is associated with morphine insensitivity in experimental neuropathic pain in the rat. Neurosci Lett 1993; 152: 129-132. (Pubitemid 23149330)
39. Noguchi K, De Leon M, Nahin RL, Senba E, Ruda MA: Quantification of axotomy-induced alteration of neuropeptide mRNAs in dorsal root ganglion neurons with special reference to neuropeptide Y mRNA and the effects of neonatal capsaicin treatment. J Neurosci Res 1993; 35: 54-66. (Pubitemid 23143632)
40. Wakisaka S, Kajander KC, Bennet GJ: Increased neuropeptide Y (NPY)-like immunoreactivity in rat sensory neurons following peripheral axotomy. Neurosci Lett 1991; 124: 200-203.
41. Noguchi K, Dubner R, De Leon M, Senba E, Ruda MA: Axotomy induces preprotachykinin gene expression in a subpopulation of dorsal root ganglion neurons. J Neurosci Res 1994; 37: 596-603. (Pubitemid 24119372)
42. Wiesenfeld-Hallin Z, Xu XJ: Galanin in somatosensory function. Ann NY Acad Sci 1998; 863: 383-389. (Pubitemid 29047788)
43. Cottrell GS, Roosterman D, Marvizon JC, Song B, Wick E, Pikios S, Wong H, Berthelier C, Tang Y, Sternini C, Bunnet NW, Grady EF: Localization of calcitonin receptor-like receptor and receptor activity modifying protein 1 in enteric neurons, dorsal root ganglia, and the spinal cord of the rat. J Comp Neurol 2005; 490: 239-255. (Pubitemid 41140991)
44. Takahashi Y, Nakajima Y: Dermatomes in the rat limbs as determined by antidromic stimulation of sensory C-fibers in spinal nerves. Pain 1996; 67: 197-202. (Pubitemid 26319653)
45. Adams ML, Brase DA, Welch SP, Dewey WL: The role of endogenous peptides in the action of opioid analgesics. Ann Emerg Med 1986; 15: 1030-1035. (Pubitemid 16017761)
46. Kraft K, Lang RR, Gaida W, Unger T, Ganten D: Angiotensin stimulates beta endorphin release from anterior pituitary gland cultures of rats. Neurosci Lett 1984; 14: 25-29. (Pubitemid 14149226)
47. Anhut H, Knepel W, Holland A, Meyer DK: Beta-endorphin release by angiotensin II: Studies on the mechanism of action. Regul Peptides 1982; 4: 83-90. (Pubitemid 13239762)
48. Beuers H, Herting G, Knepel W: Release of -lipotropin and -endorphin-like material induced by angiotensin in the conscious rat. Br J Pharmacol 1982; 76: 579-585. (Pubitemid 12095296)
49. Wright JW, Harding JW: Brain angiotensin receptor subtypes in the control of physiological and behavioral responses. Neurosci Biobehav Rev 1994; 18: 21-53. (Pubitemid 24058923)